Introduction: Talaromyces marneffei (T. marneffei), a kind of endemic opportunistic pathogen, was previously thought to occur in HIV-positive individuals and non-HIV hosts with impaired immune function. However, the infection of T.
Ling-Yan Ye +3 more
doaj +1 more source
An unusual Toll/MyD88-mediated Drosophila host defence against Talaromyces marneffei
International audienceTalaromycosis, caused by Talaromyces marneffei (T. marneffei, formerly known as Penicillium marneffei), is an opportunistic invasive mycosis endemic in tropical and subtropical areas of Asia with high mortality rate. Despite various
Qu, Qinglin +5 more
core +1 more source
Disseminated Talaromyces marneffei infection mimicking laryngitis tuberculosis
Mianluan Pan, Jianquan Zhang
openaire +3 more sources
Talaromyces marneffei Outside Endemic Regions: An Overlooked Mycosis Under a One-Health Lens
Talaromyces marneffei is a zoonotic dimorphic pathogen endemic to Southeast Asia and reported in 33 countries, with an estimated 17,300 human cases and 4900 deaths annually.
Ana Sofia Soares +5 more
core +1 more source
An HIV-negative infant with systemic Talaromyces marneffei infection [PDF]
Min, Lei +3 more
openaire +2 more sources
Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis. [PDF]
Thu NTM +15 more
europepmc +1 more source
332 Genetic susceptibility to Talaromyces marneffei infection [PDF]
openaire +1 more source
Antifungal Susceptibility Testing and Cytokine Analysis in Patients with HIV-1/AIDS Complicated by <i>Talaromyces marneffei</i> Infection in Yunnan Province. [PDF]
Gao L +6 more
europepmc +1 more source
Multiple recurrences of Talaromyces marneffei infection with HLH in an HIV-negative patient: a case report. [PDF]
Zhu L, Liu Y, Tao R, You L.
europepmc +1 more source
In Vitro Evaluation of Olorofim and Amphotericin B Combination Therapy Against <i>Talaromyces marneffei</i>. [PDF]
Lan LHN +9 more
europepmc +1 more source

